Pay in 4 interest-free payments of $6.57 Learn more
Ships within 48 hours · Estimated delivery Oct 18 - Oct 23
These outcomes could transition to us successfully, but most human evidence is anecdotal
Results from these trials are expected by late 2026
8 Further information is provided in three additional papers that reported data from the RAND Interstitial Cystitis Epidemiology (RICE) study
It's water-soluble, so your body flushes out what it doesn't use, and there's no established toxic dose for healthy people
The Injection (Subcutaneous) - Dosing: Once weekly - Bioavailability: ~100% (bypasses GI tract) - Weight loss in trials: Up to 22% at 36 weeks - Best for: Patients seeking maximum efficacy, comfortable with self-injection The Pill (Oral) - Dosing: Once daily (taken on an empty stomach, similar to Rybelsus) - Bioavailability: Lower than SC (relies on SNAC absorption technology) - Weight loss in trials: Up to 13.1% at 12 weeks (Phase 1 short duration) - Best for: Injection-averse patients, early treatment, maintenance, broader access The oral formulation will almost certainly deliver less weight loss than the subcutaneous version at equivalent treatment durations
US$ 23.25
US$ 21.88
US$ 20.51
US$ 22.98
US$ 20.46
US$ 28.99
US$ 27.28
US$ 22.26
